Literature DB >> 28931330

Sequential molecular changes and dynamic oxidative stress in high-grade serous ovarian carcinogenesis.

Hiroshi Kobayashi1, Kenji Ogawa1, Naoki Kawahara1, Kana Iwai1, Emiko Niiro1, Sachiko Morioka1, Yuki Yamada1.   

Abstract

The mechanism of high-grade serous ovarian cancer (HGSC) development remains elusive. This review outlines recent advances in the understanding of sequential molecular changes associated with the development of HGSC, as well as describes oxidative stress-induced genomic instability and carcinogenesis. This article reviews the English language literature between 2005 and 2017. Clinicopathological features analysis provides a sequential progression of fallopian tubal epithelium to precursor lesions to type 2 HGSC. HGSC may develop over a long time after incessant ovulation and repeated retrograde menstruation via stepwise accumulation of genetic alterations, including PAX2, ALDH1A1, STMN1, EZH2 and CCNE1, which confer positive selection of cells with growth advantages through acquiring driver mutations such as BRCA1/2, p53 or PTEN/PIK3CA. Haemoglobin and iron-induced oxidative stress leads to the emergence of genetic alterations in fallopian tubal epithelium via increased DNA damage and impaired DNA repair. Serous tubal intraepithelial carcinoma (STIC), the likely precursor of HGSC, may be susceptible to DNA double-strand breaks, exhibit DNA replication stress and increase genomic instability. The induction of genomic instability is considered to be a driving mechanism of reactive oxygen species (ROS)-induced carcinogenesis. HGSC exemplifies the view of stepwise cancer development. We describe how genetic alterations emerge during HGSC carcinogenesis related to oxidative stress.

Entities:  

Keywords:  Genomic mutations; high-grade serous ovarian cancer; oxidative stress; p53 mutations; serous tubal intraepithelial carcinoma

Mesh:

Year:  2017        PMID: 28931330     DOI: 10.1080/10715762.2017.1383605

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  7 in total

1.  Sestrin family of genes and their role in cancer-related fatigue.

Authors:  Velda J Gonzalez-Mercado; Brooke L Fridley; Leorey N Saligan
Journal:  Support Care Cancer       Date:  2018-03-12       Impact factor: 3.603

Review 2.  The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination.

Authors:  Sabrina J Ritch; Carlos M Telleria
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-28       Impact factor: 6.055

3.  Expression of EZH2 and P53 and their correlation in ovarian cancer tissues.

Authors:  Li Zhai; Wen-Lin Tai; Yu-Qing Pan; Jian-Bo Luo; Li Ma; Ya-Ting Zheng; Meng-Yue Guo; Xi Zhang
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

4.  EZH2 Inhibition Ameliorates Transverse Aortic Constriction-Induced Pulmonary Arterial Hypertension in Mice.

Authors:  Zhan-Li Shi; Kun Fang; Zhi-Hui Li; Dan-Hong Ren; Jia-Ying Zhang; Jing Sun
Journal:  Can Respir J       Date:  2018-02-28       Impact factor: 2.409

Review 5.  Interplay Between MicroRNAs and Oxidative Stress in Ovarian Conditions with a Focus on Ovarian Cancer and Endometriosis.

Authors:  Josep Marí-Alexandre; Antonio Pellín Carcelén; Cristina Agababyan; Andrea Moreno-Manuel; Javier García-Oms; Silvia Calabuig-Fariñas; Juan Gilabert-Estellés
Journal:  Int J Mol Sci       Date:  2019-10-25       Impact factor: 5.923

Review 6.  Insights into the Role of Oxidative Stress in Ovarian Cancer.

Authors:  Dan-Ni Ding; Liang-Zhen Xie; Ying Shen; Jia Li; Ying Guo; Yang Fu; Fang-Yuan Liu; Feng-Juan Han
Journal:  Oxid Med Cell Longev       Date:  2021-10-07       Impact factor: 6.543

7.  ROS scavengers decrease γH2ax spots in motor neuronal nuclei of ALS model mice in vitro.

Authors:  Maya Junghans; Felix John; Hilal Cihankaya; Daniel Schliebs; Konstanze F Winklhofer; Verian Bader; Johann Matschke; Carsten Theiss; Veronika Matschke
Journal:  Front Cell Neurosci       Date:  2022-08-31       Impact factor: 6.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.